Cited by 18Global Cancer Incidence and ScreeningPancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

The DOI matches its Crossref record.

Differences in Pancreatic Cancer Incidence Rates and Temporal Trends Across Asian Subpopulations in California (1988–2015)

Open access

Abstract

Objective: Ethnic disparities in pancreatic cancer (PanCan) incidence exist, but little is known about incidence trends in heterogeneous Asian Americans. We examined PanCan incidence and temporal patterns among detailed ethnic populations, including Asian American subgroups. Methods: A total of 71,099 invasive exocrine PanCan cases were identified using the California Cancer Registry between 1988 and 2015. Cases were grouped into mutually exclusive groups of non-Hispanic (NH) white, NH black, Hispanic, NH Asian/Pacific Islander (API), and NH American Indian/Alaska Native (AIAN). Asians were further identified by specific ethnicity. Results: The age-adjusted incidence rates (AAIRs, per 100,000) of PanCan varied significantly across racial/ethnic groups, ranging from the highest of 10.4 in NH blacks to 7.6 in NH whites, 7.1 in Hispanics, 6.2 in NH APIs, and to the lowest of 5.2 in NH AIAN. Despite the relatively low rate in the NH APIs, the rates across Asian subgroups varied significantly, with rates similar to NH whites in Japanese (8.1) and Koreans (7.5) to the low rate in South Asians (4.4). Conclusions: Significant heterogeneity of PanCan incidence in disaggregated Asian Americans is a novel finding. These results fill a gap regarding PanCan burden in Asian Americans and underscore the importance of disaggregating ethnic populations in cancer research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/mpa.0000000000001337

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Several studies show that the probability PDAC development can be further increased by including additional factors such as weight change, ethnicity, and lifestyle factors that are commonly contained in electronic medical records.

    “Of note, several studies show that the probability PDAC development can be further increased by including additional factors such as weight change, ethnicity, and lifestyle factors that are commonly contained in electronic medical records.171–178”

    From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [175]

    The Results (page unavailable) report significant differences in pancreatic cancer incidence across racial and ethnic groups, supporting ethnicity as relevant to risk. The paper does not show that adding ethnicity, weight change, or lifestyle factors increases the predicted probability of PDAC development, nor does it assess an electronic-medical-records prediction model. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Surgery is the only therapy to date associated with a durable long-term outcome.

    “This result is based on the findings that surgery is the only therapy to date associated with a durable long-term outcome.”

    From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [166]

    The Conclusions discuss pancreatic cancer incidence and trends across Asian subgroups, not treatment outcomes (page unavailable in our copy). Searches for the quoted assertion and for surgical resection and long-term survival found no passage saying surgery is the only therapy associated with a durable long-term outcome. (LLM, conf=0.76)

    Experimental — accuracy not yet measured
  • The Chronic Pancreatitis, Diabetes, and Pancreatic Cancer group seeks to understand the clinical, epidemiological, and biological characteristics of patients with chronic pancreatitis and NOD, including the subsequent risk of pancreatic cancer.

    “Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (https://cpdpc.mdanderson.org/) seeks to understand the clinical, epidemiological, and biological characteristics of patients with chronic pancreatitis and NOD, including the subsequent risk of pancreatic cancer.166”

    From Artificial Intelligence and Early Detection of Pancreatic Cancer: 2020 Summative Review (2021) · cites this paper as [166]

    Split into 2 atoms — 0 confirmed, 0 partially supported, 0 disputed, 0 misattributed, 2 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 13

  1. 2018, Annual report to the nation on the status of cancer, part I: national cancer statistics, Cancer, 124, 2785, 10.1002/cncr.31551 · DOI
  2. 2018, Cancer statistics, 2018, CA Cancer J Clin, 68, 7, 10.3322/caac.21442 · DOI
  3. 2018, Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data, Int J Epidemiol, 47, 427, 10.1093/ije/dyx232 · DOI
  4. 2005, Risk of pancreatic adenocarcinoma: disparity between African Americans and other race/ethnic groups, Cancer, 103, 349, 10.1002/cncr.20771 · DOI
  5. 2017, Racial disparity in gastrointestinal cancer risk, Gastroenterology, 153, 910, 10.1053/j.gastro.2017.08.018 · DOI
  6. 2005, Cancer health disparities among Asian Americans: what we do and what we need to do, Cancer, 104, 2895
  7. 2018, Striking racial/ethnic disparities in liver cancer incidence rates and temporal trends in California, 1988–2012, J Natl Cancer Inst, 110, 1259, 10.1093/jnci/djy051 · DOI
  8. 2013, Cancer incidence trends among Asian American populations in the United States, 1990–2008, J Natl Cancer Inst, 105, 1096, 10.1093/jnci/djt157 · DOI
  9. 2007, Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities, CA Cancer J Clin, 57, 190, 10.3322/canjclin.57.4.190 · DOI
  10. 2008, Cancer incidence and mortality patterns among specific Asian and Pacific Islander populations in the U.S, Cancer Causes Control, 19, 227, 10.1007/s10552-007-9088-3 · DOI
  11. 2010, Cervical cancer incidence among 6 asian ethnic groups in the United States, 1996 through 2004, Cancer, 116, 949, 10.1002/cncr.24843 · DOI
  12. 2012, Invasive breast cancer incidence trends by detailed race/ethnicity and age, Int J Cancer, 130, 395, 10.1002/ijc.26004 · DOI
  13. 2013, The epidemiology of pancreatitis and pancreatic cancer, Gastroenterology, 144, 1252, 10.1053/j.gastro.2013.01.068 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Liu, L., Zhang, J., Deapen, D., Stern, M. C., Sipin, A., Pandol, S. J., & Setiawan, V. W.
Affiliations
  • University of Southern California (US)
  • Department of Preventive Medicine, Keck School of Medicine, University of Southern California;
  • Cedars-Sinai Medical Center (US)
Corresponding author
  • Liu, Lihua
  • Zhang, Juanjuan
  • Deapen, Dennis
  • Stern, Mariana C.
  • Setiawan, Veronica Wendy
Venue
Pancreas
Published
2019-06-10
Volume
48
Issue
7
Pages
931-933
ISSN
  • 0885-3177 (ISSN-L)
  • 1536-4828
OpenAlex
W2950903274
Cited by
18
References
0
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 4
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Pancreas (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (HHSN261201000034 C, HHSN261201000035C, HHSN261201000140C, HHSN261201000035I, U54CA233396, U54CA233444, U54CA233465)
  • National Center for Chronic Disease Prevention and Health Promotion (U58 DP003862)
Topics
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
  • Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
Keywords
pancreatic cancer, cancer incidence, ethnic disparities, Asian Americans, Asian subgroups, temporal trends, racial and ethnic disparities, Japanese Americans, Korean Americans, South Asian Americans, Pacific Islanders, American Indians and Alaska Natives, Hispanic population, California
MeSH terms
Adult, Aged, Asian, Black or African American, California, Hispanic or Latino, Humans, Middle Aged, Pancreatic Neoplasms, Registries, Incidence, White People, Native Hawaiian or Other Pacific Islander, Native Hawaiian or Pacific Islander, Pancreas, Exocrine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review